pd-1/vegfr blockade for liver cancer
Published 3 years ago • 152 plays • Length 1:23Download video MP4
Download video MP3
Similar videos
-
1:45
combined blockade of vegf and pd-1 signaling in rcc
-
1:00
the role of nt219 in enhancing anti-pd-1 efficacy
-
1:13
choosing the best treatment regimen in advanced hepatocellular carcinoma
-
1:27
dr. mcdermott on vegf/pd-1 inhibition in rcc
-
1:21
unmet needs in immunotherapy for hepatocellular carcinoma
-
4:01
the impact of targeted therapies in the treatment landscape of liver cancer
-
2:44
challenges in developing car-t cells for liver cancer
-
1:22
the current treatment landscape and future directions of combination approaches for hcc
-
0:57
combined inhibition of parp and vegf in gastric cancer
-
5:17
vegf and pd-1 inhibition in advanced gastric/gej cancer
-
1:16
how can be io for liver cancer be utilized in the transplant setting?
-
2:04
unmet needs in radiation therapy for liver cancer
-
2:46
io-io vs. io-vegf inhibitor therapy for mrcc
-
1:07
the role of pd-1 inhibitors in liver cancer
-
1:57
recent immunotherapy advances in hcc management
-
2:27
combining egfr and vegf inhibitors for nsclc
-
2:48
potential role of radiotherapy for liver cancer
-
1:08
pd-l1 potential in liver cancer
-
2:41
should pd-l1 be used as a biomarker for immunotherapy in bladder cancer?